COVID-19 rebound possible after taking Paxlovid, but no further treatment necessary: CDC

CDC warns of “COVID-19 rebound” after taking Paxlovid, an antiviral drug the FDA allows for emergency use for high risk patients with mild-to-moderate COVID-19.

Read More

Previous post Market Snapshot: U.S. stocks slide to begin June, but trade off session lows
Next post Texas plugs Biden's border gaps with razor wire and prosecutions